Researchers focus on new treatment options for diabetic macular edema

Article

Diabetic retinopathy is the most common vascular retinopathy associated with decreased visual acuity among young adults.

Researchers in the ETDRS found that focal photocoagulation was effective in reducing the risk of moderate visual loss by 50% (from 24% to 12%, 3 years after initiation of treatment) in patients with DME. Although the goal of this treatment was to halt the disease, at times, focal treatment was shown to increased the chance of visual improvement by decreasing the frequency of persistent macular edema.

For more than 20 years, the ETDRS results have been the standard of care for managing DME. The ETDRS results stimulated additional questions that remain unanswered.

For example, there was no clear recommendation for the number of re-treatments for refractory DME, and this remains one of the most challenging clinical problems clinicians still face today. Despite that, many current clinical trials continue to use the ETDRS results for comparison.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.